JobCubby JobCubby
Sign up
Liquidia

Liquidia

A biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease.

LinkedIn
Location
—
Roles tracked
0
In pipeline
0
Tracking since
—

At a glance

You're tracking 0 roles at Liquidia. Track a role to start building momentum here.

Company intel

From the job board · LinkedIn data via posting sync
Industry
Biotechnology Research
Company size
283 people
Headquarters
Morrisville, NC
Founded
2004
Type
Public Company
Total funding
$533.4M

Liquidia Corporation is a biopharmaceutical company focused on the development and commercialization of products in pulmonary hypertension and other applications of its PRINT® Technology. Liquidia has developed YUTREPIA™ (treprostinil) inhalation powder for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). Liquidia is also developing L606, an investigational liposomal formulation of treprostinil administered twice-daily with a short-duration next-generation nebulizer, for use in North America. The subsidiary Liquidia PAH provides for the commercialization of pharmaceutical products to treat pulmonary disease, such as generic Treprostinil Injection.

biopharmaceuticals materials science and alternative energy films
1 open role at Liquidia on the job board

Open roles at Liquidia